With minimally invasive surgery, surgeons use
a many techniques to operate with less injury to the body than with open
surgery. Generally speaking, minimally invasive surgery is safer than open
surgery and offers the patient the ability to recover faster and heal with less
pain and scarring. In many cases, minimally invasive surgery can be done on an
outpatient basis or requires a reduced stay in the hospital.
Cardica Inc., Redwood City, California,
designs and manufactures proprietary stapling and anastomotic devices for
cardiac and laparoscopic surgical procedures. Cardica’s technology portfolio
aims to reduce operating time and allows for minimally-invasive and
robot-assisted surgeries. Aside from the obvious goal of ultimately achieving
patient health and well-being, Cardica’s presence in this arena addresses the
ever-present conversation topics of healthcare cost reduction, expanding patient
options and improving comprehensive care.
CRDC manufactures and markets the Cardica
MicroCutter XCHANGE ® 30, a cartridge-based surgical stapling device with a
five millimeter shaft diameter, for use in a wide array of gastrointestinal
procedures and appendectomies in the US and an extensive range of surgical
procedures in Europe. The instrument is the world’s first and only articulating
5mm stapler. It is a cartridge-based system with a 5mm shaft diameter and cross
sectional area much smaller than conventional 12mm staplers, and with greater
articulation. Combining several new technologies, the device is designed to
reduce limitations on surgical procedures created by larger stapling devices.
What’s more, all ports could be stapling ports, discarding the need to upsize
trocars simply to fire the stapler. The device features 80 degrees of
articulation. A button push provides the widest reach of any stapler available
and gives push button/fingertip access to reach difficult anatomy from every
stapling port.
One of many leadership posts at Cardica Inc.
is held by Lee Swanstrom, M.D., F.A.C.S. (Fellow of the American College of
Surgeons), Medical Director. Dr. Swanstrom is an acclaimed researcher and
innovator in the field of minimally invasive surgery. He is a widely-respected
laparoscopic surgeon, who brings clinical expertise and enhanced by established
relationships with surgeons across the country. His experience leading a highly
sought-after fellowship program, and as a guest lecturer and hands-on skills
instructor in courses around the world, strengthens the company’s ability to
reach and train surgeons on the MicroCutter product line. A board-certified
surgeon, Dr. Swanstrom also has special interests in esophageal diseases and
endoscopy.
Accompanying the Cardica MicroCutter XCHANGE ®
30 is the smallest profile articulating stapler cartridge available today,
which is known to reduce the amount of tissue dissection and handling to get
the stapler in proper position to administer. Punctuating the procedure,
surgeons agree the size and degree of articulation improves access and
visualization at the stapling site. The device also uses reloadable cartridges
with a 30mm staple line length and an integrated knife. The cartridge comes
with either blue staples, for medium tissue thicknesses, or white staples, for
thin tissues such as vascular structures.
The company’s endeavors are not limited to the
MicroCutter XCHANGE ® 30. Cardica also develops, manufactures and markets its
automated anastomosis systems, the C-Port Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG)
surgery. It is worth noting that over 47,000 units have been shipped throughout
the world.
For more information on the company visit www.cardica.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
